Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Gen Kanayama, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Gen Kanayama and Harrison Pope.
Connection Strength

12.856
  1. Kanayama G, Hudson JI, Pope HG. Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians. Psychother Psychosom. 2020; 89(2):65-73.
    View in: PubMed
    Score: 0.955
  2. Kanayama G, Kaufman MJ, Pope HG. Public health impact of androgens. Curr Opin Endocrinol Diabetes Obes. 2018 06; 25(3):218-223.
    View in: PubMed
    Score: 0.848
  3. Kanayama G, Pope HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018 03 15; 464:4-13.
    View in: PubMed
    Score: 0.777
  4. Kanayama G, DeLuca J, Meehan WP, Hudson JI, Isaacs S, Baggish A, Weiner R, Micheli L, Pope HG. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study. Am J Sports Med. 2015 Nov; 43(11):2638-44.
    View in: PubMed
    Score: 0.702
  5. Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015 May; 110(5):823-31.
    View in: PubMed
    Score: 0.676
  6. Kanayama G, Kean J, Hudson JI, Pope HG. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):208-14.
    View in: PubMed
    Score: 0.580
  7. Kanayama G, Pope HG. Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes. 2012 Jun; 19(3):211-9.
    View in: PubMed
    Score: 0.559
  8. Kanayama G, Hudson JI, Pope HG. Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom. 2012; 81(2):73-8.
    View in: PubMed
    Score: 0.545
  9. Kanayama G, Pope HG. Gods, men, and muscle dysmorphia. Harv Rev Psychiatry. 2011 Mar-Apr; 19(2):95-8.
    View in: PubMed
    Score: 0.513
  10. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):6-13.
    View in: PubMed
    Score: 0.478
  11. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009 Dec; 104(12):1966-78.
    View in: PubMed
    Score: 0.470
  12. Kanayama G, Hudson JI, Pope HG. Illicit anabolic-androgenic steroid use. Horm Behav. 2010 Jun; 58(1):111-21.
    View in: PubMed
    Score: 0.464
  13. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009 Jun; 166(6):642-5.
    View in: PubMed
    Score: 0.454
  14. Kanayama G, Hudson JI, Pope HG. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009 Jun 01; 102(1-3):130-7.
    View in: PubMed
    Score: 0.449
  15. Kanayama G, Hudson JI, Pope HG. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008 Nov 01; 98(1-2):1-12.
    View in: PubMed
    Score: 0.426
  16. Kanayama G, Amiaz R, Seidman S, Pope HG. Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp Clin Psychopharmacol. 2007 Dec; 15(6):529-38.
    View in: PubMed
    Score: 0.409
  17. Kanayama G, Boynes M, Hudson JI, Field AE, Pope HG. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007 May 11; 88(2-3):156-62.
    View in: PubMed
    Score: 0.382
  18. Kanayama G, Barry S, Hudson JI, Pope HG. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry. 2006 Apr; 163(4):697-703.
    View in: PubMed
    Score: 0.365
  19. Kanayama G, Cohane GH, Weiss RD, Pope HG. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry. 2003 Feb; 64(2):156-60.
    View in: PubMed
    Score: 0.293
  20. Steele IH, Pope HG, Kanayama G. Competitive Bodybuilding: Fitness, Pathology, or Both? Harv Rev Psychiatry. 2019 Jul/Aug; 27(4):233-240.
    View in: PubMed
    Score: 0.228
  21. Kaufman MJ, Kanayama G, Hudson JI, Pope HG. Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Neurosci Biobehav Rev. 2019 05; 100:180-207.
    View in: PubMed
    Score: 0.223
  22. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23; 135(21):1991-2002.
    View in: PubMed
    Score: 0.197
  23. Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, Jensen JE, Pope HG. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015 Jul 01; 152:47-56.
    View in: PubMed
    Score: 0.171
  24. Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 Jul-Aug; 23(4):371-7.
    View in: PubMed
    Score: 0.153
  25. Brennan BP, Kanayama G, Pope HG. Performance-enhancing drugs on the web: a growing public-health issue. Am J Addict. 2013 Mar-Apr; 22(2):158-61.
    View in: PubMed
    Score: 0.146
  26. Pope HG, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012 Feb 01; 71(3):254-61.
    View in: PubMed
    Score: 0.132
  27. Brennan BP, Kanayama G, Hudson JI, Pope HG. Human growth hormone abuse in male weightlifters. Am J Addict. 2011 Jan-Feb; 20(1):9-13.
    View in: PubMed
    Score: 0.126
  28. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, Pope HG. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010 Jul; 3(4):472-6.
    View in: PubMed
    Score: 0.121
  29. Pope HG, Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, Kanayama G, Siegel A, Hudson JI, Seidman SN. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol. 2010 Apr; 30(2):126-34.
    View in: PubMed
    Score: 0.120
  30. Grelotti DJ, Kanayama G, Pope HG. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry. 2010 Jan; 167(1):17-23.
    View in: PubMed
    Score: 0.118
  31. Pope HG, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid users' attitudes towards physicians. Addiction. 2004 Sep; 99(9):1189-94.
    View in: PubMed
    Score: 0.082
  32. Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2004 Nov; 176(3-4):239-47.
    View in: PubMed
    Score: 0.081
  33. Kanayama G, Pope HG, Cohane G, Hudson JI. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend. 2003 Jul 20; 71(1):77-86.
    View in: PubMed
    Score: 0.076
  34. Pope HG, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry. 2003 Jan; 160(1):105-11.
    View in: PubMed
    Score: 0.073
  35. Kanayama G, Gruber AJ, Pope HG, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom. 2001 May-Jun; 70(3):137-40.
    View in: PubMed
    Score: 0.065
  36. Kanayama G, Pope HG, Hudson JI. "Body image" drugs: a growing psychosomatic problem. Psychother Psychosom. 2001 Mar-Apr; 70(2):61-5.
    View in: PubMed
    Score: 0.064
  37. Hudson JI, Kanayama G, Pope HG, Muse S, Kaufman MJ, Baggish A, Waikar SS. Glomerular Filtration Rate and Supraphysiologic-Dose Anabolic-Androgenic Steroid Use: A Cross-sectional Cohort Study. Am J Kidney Dis. 2020 07; 76(1):152-155.
    View in: PubMed
    Score: 0.060
  38. Ulrich R, Pope HG, Cléret L, Petróczi A, Nepusz T, Schaffer J, Kanayama G, Comstock RD, Simon P. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys. Sports Med. 2018 01; 48(1):211-219.
    View in: PubMed
    Score: 0.051
  39. Seitz J, Lyall AE, Kanayama G, Makris N, Hudson JI, Kubicki M, Pope HG, Kaufman MJ. White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study. Psychiatry Res Neuroimaging. 2017 Feb 28; 260:1-5.
    View in: PubMed
    Score: 0.048
  40. Hallgren M, Pope HG, Kanayama G, Hudson JI, Lundin A, Källmén H. Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents. Eur Addict Res. 2015; 21(6):321-6.
    View in: PubMed
    Score: 0.043
  41. Kersey RD, Elliot DL, Goldberg L, Kanayama G, Leone JE, Pavlovich M, Pope HG. National Athletic Trainers' Association position statement: anabolic-androgenic steroids. J Athl Train. 2012 Sep-Oct; 47(5):567-88.
    View in: PubMed
    Score: 0.036
  42. Amiaz R, Pope HG, Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011; 37(4):243-54.
    View in: PubMed
    Score: 0.032
  43. Pillay SS, Rogowska J, Kanayama G, Gruber S, Simpson N, Pope HG, Yurgelun-Todd DA. Cannabis and motor function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharmacol. 2008 Feb; 16(1):22-32.
    View in: PubMed
    Score: 0.026
  44. Pillay SS, Rogowska J, Kanayama G, Jon DI, Gruber S, Simpson N, Cherayil M, Pope HG, Yurgelun-Todd DA. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. Drug Alcohol Depend. 2004 Dec 07; 76(3):261-71.
    View in: PubMed
    Score: 0.021
  45. Negus SS, Pope HG, Kanayama G, Wines JD, Fischer BD. Lack of evidence for opioid tolerance or dependence in rhesus monkeys following high-dose anabolic-androgenic steroid administration. Psychoneuroendocrinology. 2001 Nov; 26(8):789-96.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.